|
COPYRIGHT 2004 International Medical News Group
MIAMI BEACH -- Gestational exposure to azithromycin was not associated with an increased risk above baseline for major fetal anomalies in a prospective, controlled trial of 369 pregnant women.
The antibiotic had a safety profile comparable to the profiles of other nonteratogenic agents.
The results suggest that the drug may be a good first-line choice for some infections in pregnancy, particularly among traditionally noncompliant populations, because of its demonstrated...
Read the full article for free courtesy of your local library.
| 
Bookmark this article
Print this article
Link to this article
Email this article
Digg It!
Add to del.icio.us
RSS
